Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Peters

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Protocols in Microbiology|February 15, 2013
Human immunodeficiency viruses: propagation, quantification, and storagePaul J Peters, Kathryn Richards, Paul Clapham
Journal of Virology|April 29, 2004
Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particlesJayanta Bhattacharya, Paul J Peters, Paul R Clapham
AIDS (London, England)|April 15, 2004
CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivoJayanta Bhattacharya, Paul J Peters, Paul R Clapham
Journal of Virology|January 9, 2009
Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopesMaria José Duenas-Decamp, Paul J Peters, Dennis Burton, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissuesPaul J Peters, Maria J Dueñas-Decamp, W Matthew Sullivan, et al.
Antiviral Research|September 15, 2005
Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor densitySamantha Willey, Paul J Peters, W Matthew Sullivan, et al.
Journal of Drug Delivery|December 15, 2016
Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human MacrophagesErnesto R Soto, Olivia O'Connell, Fusun Dikengil, et al.
Retrovirology|March 27, 2015
HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophagesThomas Musich, Olivia O'Connell, Maria Paz Gonzalez-Perez, et al.
Journal of Virology|June 15, 2004
Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophagesPaul J Peters, Jayanta Bhattacharya, Samantha Hibbitts, et al.
Archives of Virology|November 12, 2018
No detection of CD4-independent human immunodeficiency virus 1 envelope glycoproteins in brain tissue of patients with or without neurological complicationsBriana Quitadamo, Paul J Peters, Matthew Koch, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Protocols in Microbiology|February 15, 2013
Human immunodeficiency viruses: propagation, quantification, and storagePaul J Peters, Kathryn Richards, Paul Clapham
Journal of Virology|April 29, 2004
Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particlesJayanta Bhattacharya, Paul J Peters, Paul R Clapham
AIDS (London, England)|April 15, 2004
CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivoJayanta Bhattacharya, Paul J Peters, Paul R Clapham
Journal of Virology|January 9, 2009
Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopesMaria José Duenas-Decamp, Paul J Peters, Dennis Burton, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissuesPaul J Peters, Maria J Dueñas-Decamp, W Matthew Sullivan, et al.
Antiviral Research|September 15, 2005
Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor densitySamantha Willey, Paul J Peters, W Matthew Sullivan, et al.
Journal of Drug Delivery|December 15, 2016
Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human MacrophagesErnesto R Soto, Olivia O'Connell, Fusun Dikengil, et al.
Retrovirology|March 27, 2015
HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophagesThomas Musich, Olivia O'Connell, Maria Paz Gonzalez-Perez, et al.
Journal of Virology|June 15, 2004
Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophagesPaul J Peters, Jayanta Bhattacharya, Samantha Hibbitts, et al.
Archives of Virology|November 12, 2018
No detection of CD4-independent human immunodeficiency virus 1 envelope glycoproteins in brain tissue of patients with or without neurological complicationsBriana Quitadamo, Paul J Peters, Matthew Koch, et al.
Pageof 2